Using Drug Levels in the Blood to Guide Therapy in HIV Infected Patients Taking a Protease Inhibitor

NCT00041769 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

360

Enrollment

NIH

Sponsor class

Conditions

HIV Infections

Interventions

PROCEDURE: Therapeutic Drug Monitoring (TDM)

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)